Price $2.26 |
Market Cap
296.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.75
|
P/S
17.37
|
Dividend %
-
|
|
P/CF
5.5
|
P/FCF
-
|
Op. Cash Flow
-37.6K
|
FCF
-0.2
|
|
Op. Margin
-302.90%
|
Net Margin
-300.60%
|
ROE
-61.10%
|
ROI
-37.30%
|
|
ROA
-55.10%
|
EPS Growth
16.50%
|
Current Ratio
11.8
|
Debt/Equity
0.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AdvanSource Biomaterials Corpo (ASNB) | $0.10 | - | - | 1.6M | Strong Buy |
| American Renal Associates Hold (ARA) | $14.13 | - | - | 448.3M | Strong Buy |
| Palatin Technologies, Inc. (PTN) | $0.66 | - | - | 65.7M | Strong Buy |
| AMAG Pharmaceuticals, Inc. (AMAG) | $18.45 | - | - | 589.3M | Strong Buy |
| iCAD Inc (ICAD) | $3.56 | - | - | 65.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
